DNA Microarray Market - By Product (Consumables, Instruments), Type (Complementary DNA Microarrays, Oligonucleotide DNA Microarrays), Application (Gene Expression Analysis), End-user (Academic & Research Institute), Global Forecast (2023

Description

List of Tables

Global DNA Microarray Market will witness 8.7% CAGR between 2023 and 2032, driven by an upsurge in partnerships and strategic collaborations for research and development. As the industry witnesses a surge in collaborative efforts, the DNA microarray market size will grow substantially. For instance, in October 2022, Illumina Inc., renowned for its global leadership in DNA sequencing and array-based technologies, revealed a strategic research collaboration with AstraZeneca, a prominent science-led biopharmaceutical company.

This partnership aims to expedite drug target discovery by leveraging their respective strengths in artificial intelligence (AI)-based genome interpretation and genomic analysis techniques, complemented by their extensive industry expertise. The collaborative effort will assess the potential of a combined framework utilizing these technologies to enhance the efficiency and confidence of target discovery, ultimately identifying promising drugs based on insights derived from human omics data. These partnerships leverage collective expertise and resources to propel advancements in genomic research, fostering innovation and driving the adoption of DNA microarray technologies in various scientific and medical applications.

The overall DNA Microarray Market is classified based on application, end-user, and region.

Gene expression analysis segment will undergo significant development from 2023 to 2032. As researchers and scientists focus on unraveling the complexities of gene expression patterns, the need for high-throughput and precise technologies like DNA microarrays becomes crucial. This DNA microarray market demand is driven by the quest for deeper insights into the functioning of genes, contributing to advancements in genomics and personalized medicine.

Pharmaceutical and biotechnology companies segment will register a noteworthy CAGR from 2023 to 2032. As these industries intensify their efforts in genomic research for drug discovery and development, DNA microarrays play a pivotal role in high-throughput analysis. Their ability to simultaneously analyze thousands of genes accelerates research, aiding in the identification of potential drug targets and facilitating advancements in precision medicine and therapeutic interventions. Therefore, the rising adoption and usage by pharmaceutical companies justifies their contribution to the DNA microarray market growth.

Asia Pacific DNA microarray market will showcase an appreciable CAGR from 2023 to 2032. With increasing investments in genomics and life sciences research, countries in the Asia Pacific contribute significantly to the market growth. The increasing focus on personalized medicine and advancements in healthcare infrastructure propel the adoption of DNA microarrays, fostering innovation and scientific progress in genomic studies within the region.

Product Code: 6689

Chapter 1 Methodology & Scope

1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 DNA microarray industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Product trends
- 2.1.4 Type trends
- 2.1.5 Application trends
- 2.1.6 End-user trends

Chapter 3 DNA Microarray Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing adoption of DNA microarray for various applications
  - 3.2.1.2 Increasing prevalence of genetic disorders and cancers
  - 3.2.1.3 Growing research activities
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost involved in the sequencing
  - 3.2.2.2 Availability of cost effective alternative
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By type
- 3.3.3 By application
- 3.3.4 By end-user
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 DNA Microarray Market, By Product, 2018 - 2032 (USD Million)

5.1 Key trends, by product
5.2 Consumables
5.3 Instruments
5.4 Software & services

Chapter 6 DNA Microarray Market, By Type, 2018 - 2032 (USD Million)

6.1 Key trends, by type
6.2 Complementary DNA microarrays
6.3 Oligonucleotide DNA microarrays
6.4 Other types

Chapter 7 DNA Microarray Market, By Application, 2018 - 2032 (USD Million)

7.1 Key trends, by application
7.2 Gene expression analysis
7.3 Genotyping
7.4 Transcription factor binding analysis
7.5 Other applications

Chapter 8 DNA Microarray Market, By End-user, 2018 - 2032 (USD Million)

8.1 Key trends, by end-user
8.2 Academic & research institute
8.3 Pharmaceutical and biotechnology companies
8.4 Diagnostic centers
8.5 Hospitals and clinics
8.6 Other end-users

Chapter 9 DNA Microarray Market, By Region, 2018 - 2032 (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East & Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

10.1 Thermo Fisher Scientific, Inc
10.2 QIAGEN
10.3 Illumina, Inc.
10.4 Agilent Technologies, Inc.
10.5 Merck & Co., Inc.
10.6 bioMérieux SA
10.7 PerkinElmer, Inc.
10.8 Bio-Rad Laboratories
10.9 Arrayit Corporation
10.10 Takara Bio Inc